TY  - JOUR
AU  - Decara, Juan M
AU  - Vazquez-Villa, Henar
AU  - Brea, Jose
AU  - Alonso, Monica
AU  - Srivastava, Raj Kamal
AU  - Orio, Laura
AU  - Alen, Francisco
AU  - Suarez, Juan
AU  - Baixeras, Elena
AU  - Garcia-Carceles, Javier
AU  - Escobar-Peña, Andrea
AU  - Lutz, Beat
AU  - Rodriguez, Ramon
AU  - Codesido, Eva
AU  - Garcia-Ladona, F Javier
AU  - Bennett, Teresa A
AU  - Ballesteros, Juan A
AU  - Cruces, Jacobo
AU  - Loza, Maria I
AU  - Benhamu, Bellinda
AU  - Rodriguez-de-Fonseca, Fernando
AU  - Lopez-Rodriguez, Maria L
PY  - 2022
DO  - 10.1021/acs.jmedchem.1c01842
UR  - http://hdl.handle.net/10668/22590
T2  - Journal of medicinal chemistry
AB  - Peptidic agonists of the glucagon-like peptide-1 receptor (GLP-1R) have gained a prominent role in the therapy of type-2 diabetes and are being considered for reducing food intake in obesity. Potential advantages of small molecules acting as positive...
LA  - en
PB  - American Chemical Society
KW  - Eating
KW  - Insulin Secretion
KW  - Glucose
KW  - Administration, Oral
KW  - Animals
KW  - Diabetes Mellitus, Type 2
KW  - Glucagon-Like Peptide-1 Receptor
KW  - Obesity
KW  - Peptides
TI  - Discovery of V-0219: A Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor toward Oral Treatment for "Diabesity".
TY  - research article
VL  - 65
ER  -